5F-203
Based on 1 Customer Validation
5F-203 (NSC-703786) is an aryl hydrocarbon receptor (AhR) agonist and the active moiety of the water-soluble benzothiazole prodrug Phortress (HY-103223). 5F-203 binds to cytosolic AhR and induces CYP1A1 and CYP1B1 expression. 5F-203 activates AhR signaling to induce DNA damage, cell cycle arrest, apoptosis, caspase-3/-7 activation, lysosomal membrane permeabilization, and Cathepsin B release. 5F-203 induces CYGB and pro-apoptotic protein expression and NAG-1 mRNA/protein induction through RNA stabilization. 5F-203 is used in research related to cancers such as triple-negative breast cancer and colorectal cancer.
For research use only. We do not sell to patients.
- Purity : 98.04%
- CAS No.: 260443-89-8
- Formula: C14H11FN2S
- Molecular Weight:258.32
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
|
CYP1A1 |
CYP1B1 |
Cathepsin B |
Caspase 3 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDA-MB-468 | IC50 |
11.17 nM
|
Inhibition of cell growth in parental MDA-MB-468 cells incubated for 72 hrs by Cell Counting Kit-8 assay.
Inhibition of cell growth in parental MDA-MB-468 cells incubated for 72 hrs by Cell Counting Kit-8 assay.
|
41628058 |
| MDA-MB-453 | IC50 |
25.58 nM
|
Inhibition of cell growth in MDA-MB-453 cells incubated for 72 hrs by Cell Counting Kit-8 assay.
Inhibition of cell growth in MDA-MB-453 cells incubated for 72 hrs by Cell Counting Kit-8 assay.
|
41628058 |
| DU-4475 | IC50 |
>500 nM
|
Inhibition of cell growth in DU4475 cells incubated for 72 hrs by Cell Counting Kit-8 assay.
Inhibition of cell growth in DU4475 cells incubated for 72 hrs by Cell Counting Kit-8 assay.
|
41628058 |
| Hs-578T | IC50 |
>500 nM
|
Inhibition of cell growth in Hs578T cells incubated for 72 hrs by Cell Counting Kit-8 assay.
Inhibition of cell growth in Hs578T cells incubated for 72 hrs by Cell Counting Kit-8 assay.
|
41628058 |
In Vitro
5F-203 is the active moiety of the benzothiazole prodrug Phortress (HY-103223) and undergoes aryl hydrocarbon receptor binding, cytochrome P450 1A1 induction, and DNA adduct formation[1].
5F-203 effectively induces NAG-1 expression in HCT-116 and MCF-7 cells; it achieves NAG-1 upregulation by enhancing the stability of NAG-1 RNA[5].
5F-203 (1-1000 nM; 24 h) induces dose-dependent apoptosis in MDA-MB-468 and T47D cells and induces caspase-3/7 activation, a process promoted by CYGB[2].
5F-203 (1 μM; 72 h) induces CYGB protein expression and pro-apoptotic protein expression in MDA-MB-468 cells, in which GADD45a, LTA, and caspase cleavage are dependent on CYGB[2].
5F-203 (100 nM; 24 h) induces the expression of pro-apoptotic genes BAK-1, LTA, and GADD45a in MDA-MB-468 cells; it inhibits MDA-MB-468 cell migration, a process associated with CYGB[2].
5F-203 (100 nM-1 μM; 24 h) induces CYGB-dependent lysosomal membrane permeabilization and cathepsin B release in MDA-MB-468 and T47D cells[2].
5F-203 (0.1-1000 nM; 72 h) inhibits the growth of MDA-MB-468 cells with an IC50 of 11.17 nmol/L and inhibits the growth of MDA-MB-453 cells with an IC50 of 25.58 nmol/L, but has no growth inhibitory effect on DU4475 and Hs578T cells, with an IC50 greater than 500 nmol/L[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MDA-MB-468 and T47D
-
Concentration:1, 100, 1000 nM
-
Incubation Time:24 h
-
Result:Induced dose-dependent apoptosis in MDA-MB-468 and T47D cells.
-
Cell Line:MDA-MB-468 and T47D
-
Concentration:1 μM
-
Incubation Time:12 h
-
Result:Promoted caspase-3 activation in T47D and MDA-MB-468 cells.
Knockdown of CYGB diminished 5F-203-mediated caspase-3/7 activation.
Enforced expression of CYGB promoted caspase-3/7 activation, and 5F-203 significantly enhanced caspase-3/7 activation in these CYGB-overexpressing cells.
-
Cell Line:MDA-MB-468 and T47D
-
Concentration:100 nM (MDA-MB-468); 1 μM (T47D)
-
Incubation Time:24 h
-
Result:Caused LMP in MDA-MB-468 cells and to a lesser extent in T47D cells. 5F-203-mediated LMP was attenuated in shCYGB MDA-MB-468 cells relative to shGFP MDA-MB-468 cells.\nPromoted cathepsin B release, characterized by diffuse red fluorescent dye staining. 5F-203-mediated cathepsin B release was attenuated in shCYGB MDA-MB-468 cells relative to shGFP MDA-MB-468 cells.
-
Cell Line:MDA-MB-468
-
Concentration:1 μM
-
Incubation Time:72 h
-
Result:Induced CYGB protein expression.
Induced the expression of proapoptotic proteins BAK-1, GADD45a, and LTA, and caspase-3 cleavage was detected.
CYGB silencing diminished the ability of 5F-203 to induce GADD45a and LTA as well as caspase cleavage, but not BAK-1.
-
Cell Line:MDA-MB-468
-
Concentration:100 nM
-
Incubation Time:24 h
-
Result:5F-203-induced expression of proapoptotic BAK-1 and LTA was attenuated in shCYGB cells relative to shGFP cells.
-
Cell Line:MDA-MB-468
-
Concentration:100 nM
-
Incubation Time:24 h
-
Result:Silencing CYGB attenuated 5F-203-mediated inhibition of wound healing.
-
Cell Line:MDA‑MB‑468, MDA‑MB‑453, DU4475 and Hs578T cells
-
Concentration:0.1, 1, 10, 100, 1000 nM
-
Incubation Time:72 h
-
Result:Inhibited the growth of parental MDA‑MB‑468 cells with an IC50 of 11.17 nmol/L and suppressed the growth of MDA‑MB‑453 cells with an IC50 of 25.58 nmol/L.
Chemical Information
-
CAS No. 260443-89-8
-
Appearance Solid
-
Molecular Weight 258.32
-
Formula C14H11FN2S
-
Color Off-white to light yellow
-
SMILES
NC1=CC=C(C2=NC3=CC(F)=CC=C3S2)C=C1C
-
Synonyms
NSC-703786
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (387.12 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (9.68 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Protocol For Protein Expression And Purification
Recombinant protein expression in Escherichia coli followed by purification of a His-tagged soluble protein by immobilized metal affinity chromatography (IMAC), with optional MBP fusion and TEV tag removal when the construct includes these elements. The biological readout is production of the encoded target protein, detected as an inducible band at the expected molecular mass by SDS-PAGE and quantified by total protein assay or chromatographic absorbance; the purification readout is enrichment of the target protein in elution fractions after selective binding of polyhistidine residues to immobilized Ni2+/metal-chelate resin and elution by imidazole-containing buffer. Expression is driven by an inducible bacterial expression system, commonly T7/lac-based, in which IPTG or lactose/auto-induction activates transcription and translation of the cloned gene; lower induction temperature, lower inducer concentration, induction timing, and solubility-enhancing fusion tags can influence the frac
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
-
Data Sheet (280 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.8712 mL | 19.3558 mL | 38.7117 mL | 96.7792 mL |
| 5 mM | 0.7742 mL | 3.8712 mL | 7.7423 mL | 19.3558 mL | |
| 10 mM | 0.3871 mL | 1.9356 mL | 3.8712 mL | 9.6779 mL | |
| 15 mM | 0.2581 mL | 1.2904 mL | 2.5808 mL | 6.4519 mL | |
| 20 mM | 0.1936 mL | 0.9678 mL | 1.9356 mL | 4.8390 mL | |
| 25 mM | 0.1548 mL | 0.7742 mL | 1.5485 mL | 3.8712 mL | |
| 30 mM | 0.1290 mL | 0.6452 mL | 1.2904 mL | 3.2260 mL | |
| 40 mM | 0.0968 mL | 0.4839 mL | 0.9678 mL | 2.4195 mL | |
| 50 mM | 0.0774 mL | 0.3871 mL | 0.7742 mL | 1.9356 mL | |
| 60 mM | 0.0645 mL | 0.3226 mL | 0.6452 mL | 1.6130 mL | |
| 80 mM | 0.0484 mL | 0.2419 mL | 0.4839 mL | 1.2097 mL | |
| 100 mM | 0.0387 mL | 0.1936 mL | 0.3871 mL | 0.9678 mL |